自噬
肌萎缩侧索硬化
蛋白酶体
TARDBP公司
生物
泛素
细胞生物学
失智症
蛋白质聚集
细胞质
信号转导衔接蛋白
蛋白质降解
癌症研究
生物化学
细胞凋亡
疾病
信号转导
SOD1
痴呆
病理
医学
基因
作者
Emma L. Scotter,Caroline Vance,Agnes L. Nishimura,Youn‐Bok Lee,Han-Jou Chen,Hazel Urwin,Valentina Sardone,Jacqueline C. Mitchell,Boris Rogelj,David C. Rubinsztein,Christopher E. Shaw
摘要
TAR DNA-binding protein (TDP-43, also known as TARDBP) is the major pathological protein in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Large TDP-43 aggregates that are decorated with degradation adaptor proteins are seen in the cytoplasm of remaining neurons in ALS and FTD patients post mortem. TDP-43 accumulation and ALS-linked mutations within degradation pathways implicate failed TDP-43 clearance as a primary disease mechanism. Here, we report the differing roles of the ubiquitin proteasome system (UPS) and autophagy in the clearance of TDP-43. We have investigated the effects of inhibitors of the UPS and autophagy on the degradation, localisation and mobility of soluble and insoluble TDP-43. We find that soluble TDP-43 is degraded primarily by the UPS, whereas the clearance of aggregated TDP-43 requires autophagy. Cellular macroaggregates, which recapitulate many of the pathological features of the aggregates in patients, are reversible when both the UPS and autophagy are functional. Their clearance involves the autophagic removal of oligomeric TDP-43. We speculate that, in addition to an age-related decline in pathway activity, a second hit in either the UPS or the autophagy pathway drives the accumulation of TDP-43 in ALS and FTD. Therapies for clearing excess TDP-43 should therefore target a combination of these pathways.
科研通智能强力驱动
Strongly Powered by AbleSci AI